Market Compass January 2022

In Short

Edited by the Macro & Market Research Team. The team of analysts based in Paris, Cologne, Trieste, Milan and Prague runs qualitative and quantitative analysis on macroeconomic and financial issues. The team translates macro and quant views into investment ideas that feed into the investment process.


  • Despite risks from Omicron, we retain a positive view on the economic recovery. Vaccines and new drugs will help the economy normalise in 2022. 
  • Yet the (cautious) policy support removal and stretched valuation will dramatically cut future (beta) returns. The diversification benefit is also set to fall as policy normalises and volatility will be higher.
  • Risks are skewed towards more hawkish policy. We expect longdated bond yields to rise, yet debt sustainability and financial stability risks will cap them. Credit will beat risk-free bonds again. We predict positive, yet lower and more volatile equity returns. 
  • The three main risks lie in a policy mistake causing financial havoc, a disorderly energy transition seeing a surge in selected commodity prices and a nasty variant escaping vaccine protection. 

Download the full publication below

Market Compass January 2022

© Generali Investments, all rights reserved. This website is provided by Generali Investments Luxembourg S.A. (Generali Investments) and is considered as a marketing communication and financial promotion related its products and services. Moreover, the website may contain marketing communication and financial promotion of products and services of companies part of the multi-boutique platform coordinated by Generali Investments Partners S.p.A. Società di gestione del risparmio, and in particular of Infranity, Sycomore Asset Management, Aperture Investors LLC., Plenisfer Investments SGR, Lumyna Investments, Sosteneo Infrastructure Partners SGR, Axis Retail Partners S.p.A. and Generali Real Estate S.p.A. Società di Gestione del Risparmio.